News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Bailey Jeffrey Allen
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/21/2023 |
4
| Bailey Jeffrey Allen (Director) has filed a Form 4 on Aurinia Pharmaceuticals Inc.|
Txns:
| Granted 17,913 restricted stock units
@ $0
Granted 28,959 options to buy
@ $9.49, valued at
$274.8k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2022 |
4
| Bailey Jeffrey Allen (CEO) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Disposed of 105,133 shares
@ $0
Disposed/sold 316,919 restricted stock units
@ $0
Disposed/sold 96,000 options to buy
@ $5.18, valued at
$497.3k
Disposed/sold 160,000 options to buy
@ $4.23, valued at
$676.8k
Disposed/sold 66,805 options to buy
@ $4.36, valued at
$291.3k
Disposed/sold 840,000 options to buy
@ $3.6, valued at
$3M
Disposed/sold 1,143,467 options to buy
@ $3.66, valued at
$4.2M
|
|
| 03/11/2022 |
4
| Bailey Jeffrey Allen (CEO) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Exercised 5,333 restricted stock units
@ $0 |
|
| 01/31/2022 |
4
| Bailey Jeffrey Allen (CEO) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Granted 1,143,467 options to buy
@ $3.66, valued at
$4.2M
Granted 204,918 restricted stock units
@ $0 |
|
| 11/08/2021 |
4
| Bailey Jeffrey Allen (CEO) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Exercised 53,333 restricted stock units
@ $0 |
|
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2020 |
4
| Bailey Jeffrey Allen (CEO) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Sold 10,000 shares
@ $4.35, valued at
$43.5k
|
|
| 11/06/2020 |
4
| Bailey Jeffrey Allen (CEO) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Exercised 40,000 restricted stock units
@ $0
Granted 840,000 options to buy
@ $0
Granted 160,000 restricted stock units
@ $0 |
|
| 09/23/2020 |
4
| Bailey Jeffrey Allen (Director) has filed a Form 4 on Tekla World Healthcare Fund|
Txns:
| Bought 710 shares of beneficial interest
@ $14.18, valued at
$10.1k
|
|
| 09/23/2020 |
4
| Bailey Jeffrey Allen (Director) has filed a Form 4 on Tekla Healthcare Opportunities Fund|
Txns:
| Bought 570 shares of beneficial interest
@ $17.68, valued at
$10.1k
|
|
| 09/23/2020 |
4
| Bailey Jeffrey Allen (Director) has filed a Form 4 on TEKLA HEALTHCARE INVESTORS|
Txns:
| Bought 490 shares of beneficial interest
@ $20.39, valued at
$10k
|
|
| 09/23/2020 |
4
| Bailey Jeffrey Allen (Director) has filed a Form 4 on TEKLA LIFE SCIENCES INVESTORS|
Txns:
| Bought 580 shares of beneficial interest
@ $17.28, valued at
$10k
|
|
| 08/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
4
| Bailey Jeffrey Allen (Director) has filed a Form 4 on AILERON THERAPEUTICS INC|
Txns:
| Granted 12,500 options to buy
@ $1.15, valued at
$14.4k
|
|
| 05/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2019 |
4
| Bailey Jeffrey Allen (Director) has filed a Form 4 on AILERON THERAPEUTICS INC|
Txns:
| Granted 50,000 options to buy
@ $0.86, valued at
$43k
|
|
| 06/25/2018 |
4
| Bailey Jeffrey Allen (Director) has filed a Form 4 on AILERON THERAPEUTICS INC|
Txns:
| Granted 10,000 options to buy
@ $6.02, valued at
$60.2k
|
|
| 03/19/2018 |
4
| Bailey Jeffrey Allen (Director) has filed a Form 4 on AILERON THERAPEUTICS INC|
Txns:
| Granted 20,000 options to buy
@ $9.02, valued at
$180.4k
|
|
| 10/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/23/2016 |
4
| Bailey Jeffrey Allen (Director) has filed a Form 4 on LANDAUER INC|
Txns:
| Granted 3,959 shares
@ $0 |
|
| 08/31/2015 |
4
| Bailey Jeffrey Allen (CEO and President) has filed a Form 4 on Lantheus Holdings, Inc.|
Txns:
| Disposed/sold 181,494 shares
@ $0 |
|
| 07/17/2015 |
4
| Bailey Jeffrey Allen (CEO and President) has filed a Form 4 on Lantheus Holdings, Inc.|
Txns:
| Granted 40,000 shares
@ $0 |
|
| 06/25/2015 |
4
| Bailey Jeffrey Allen (CEO and President) has filed a Form 4 on Lantheus Holdings, Inc.|
Txns:
| Disposed/sold 177,936 options to buy
@ $19.11, valued at
$3.4M
Granted 177,936 options to buy
@ $19.11, valued at
$3.4M
|
|
| 04/17/2015 |
4
| Bailey Jeffrey Allen (Director) has filed a Form 4 on LANDAUER INC|
Txns:
| Granted 2,724 shares
@ $0 |
|
| 03/01/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|